Inotiv, Inc. — Director's Dealing 2016

May 16, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2016-05-09

Reporting Person: Blumhoff Jill (VP, Finance & CFO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$5.09	2018-09-04	Common Shares (2000)		Direct
Employee Stock Option (right to buy)	$1.01	2020-08-15	Common Shares (2000)		Direct
Employee Stock Option (right to buy)	$1.40	2023-01-16	Common Shares (500)		Direct
Employee Stock Option (right to buy)	$1.70	2025-09-14	Common Shares (10000)		Direct

Footnotes

F1: The option became exercisable in four equal annual installments. The first installment became exercisable on September 4, 2010, and the next three installments became exercisable on September 4, 2011, September 4, 2012 and September 4, 2013.

F2: The option became exercisable in four equal annual installments. The first installment became exercisable on August 16, 2012, and the next three installments became exercisable on August 16, 2013, August 16, 2014 and August 16, 2015.

F3: The option became exercisable in two equal annual installments. The first installment became exercisable on January 16, 2014 and the second installment became exercisable on January 16, 2015.

F4: The option will become exercisable in four equal annual installments. The first installment will become exercisable on September 15, 2016, and the next three installments will become exercisable on September 15, 2017, September 15, 2018 and September 15, 2019.